FDA Inspection 1180193 — Vitalant
The FDA completed an inspection of Vitalant on Sep 14, 2022 in Merced, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Merced, CA (United States)